Rising energy costs, challenges in accessing supplies and rapidly changing technology are all factors that mean industry needs a certain and established regulatory structure to help it cope.
The EU medtech industry is calling for European Commission support in building a fully operational regulatory system for medical devices to help provide a ballast during the current unsettling environment in Europe.
The aftermath of the COVID-19 pandemic combined with the war in Ukraine is having a detrimental effect on access to medical technologies in Europe, with challenges in accessing and sourcing key materials,
Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.
Post-market surveillance regulations for medtech system users in Great Britain coming into force on 16 June will make new data requirements under new compliance deadlines.
The consumer genomics firm will operate as a subsidiary, while Regeneron plans to leverage its database for drug discovery and trial design efforts.
FemTech leaders discussed some of the barriers that remain in unlocking the full potential of the women’s health market during SiS New York last week. They also offered solutions.
FemTech leaders discussed some of the barriers that remain in unlocking the full potential of the women’s health market during SiS New York last week. They also offered solutions.
Despite regional unrest, it is business as usual for medtech innovators and investors in Israel as evidenced by continued high-value M&A of locally developed technologies. Irit Yaniv, co-chair of the medtech session at the upcoming BioMed Israel 2025, explained the unique dynamics of Israeli medtech innovation.
Communication with patients has become a particularly crucial factor for investors, payers, and other healthcare decision-makers in a hostile market environment.
